CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
We received an updated WNV package insert; please note the manufacturer and license number has been ...